Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT? (E4E)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by WHO, Department of Maternal, Newborn, Child and Adolescent Health
Sponsor:
Collaborators:
Canadian International Development Agency
Netherlands: Ministry of Health, Welfare and Sports
Information provided by (Responsible Party):
WHO, Department of Maternal, Newborn, Child and Adolescent Health
ClinicalTrials.gov Identifier:
NCT02070900
First received: February 18, 2014
Last updated: February 20, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)